Furthermore, the interpretation might be complicated by a lack of evidence in the association of high cancer risk with genetic forms of hypoalphalipoproteinemia, namely familial LCAT deficiency, familial HDL deficiency due to ABCA1 gene mutations, and familial apoAI deficiency [58]. This evidence concerns the gene ABCA1 and hypoalphalipoproteinemia.